関連する実験動画
Updated: May 10, 2026

12:19
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
E2F1-DP1に結合するRb C端末ドメインの構造:E2Fをリン酸化によって誘導するE2F放出のメカニズム
Seth M Rubin1, Anne-Laure Gall, Ning Zheng
1Structural Biology Program and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, NY 10021, USA.
Cell
|December 20, 2005
まとめ
レチノブラストーマ (Rb) タンパク質は,
科学分野:
- 細胞サイクル調節 細胞サイクル調節
- 分子生物学は分子生物学である.
- タンパク質とタンパク質の相互作用
背景:
- 網膜芽細胞腫 (Rb) タンパク質は,細胞サイクルにおけるG1-S相移行の主要な調節体である.
- RbはE2F転写因子と結合し,サイクリン依存キナーゼによってリン酸化されるまでその活性を抑制する.
- RbポケットドメインがE2F結合を媒介する一方で,C端末ドメイン (RbC) も成長抑制に不可欠です.
研究 の 目的:
- RbC端末ドメイン (RbC) とE2F-DPヘテロダイマー間の相互作用の構造的基礎を解明する.
- 高親和のE2F結合と成長抑制におけるRbCの役割を理解する.
- リン酸化がRb-E2F相互作用を調節するメカニズムを調査する.
主な方法:
- タンパク質の相互作用を確認するための共免疫プレシピテーションアッセイ.
- RbC-E2F1-DP1複合体の構造を決定するためのX線結晶学.
- Rb-E2F結合に対するリン酸化の影響を研究するためのサイト指向型変異.
主要な成果:
- RbCとE2F-DPヘテロダイマー間の高親和相互作用が特定されました.
- 結晶構造は,E2F1とDP1のマークされたボックスドメインがRbCと接触する交絡したヘテロダイマーを明らかにしました.
- 特定の部位でのRbCのリン酸化 (Ser788/795およびThr821/826) は,直接的および間接的なメカニズムを通じてRb-E2F相互作用を不安定化することが示されました.
結論:
- Rb C末端ドメイン (RbC) は,E2F-DPヘテロダイマーへの高親和結合に不可欠であり,成長抑制に寄与する.
- 結晶構造は,RbC-E2F-DP複合体の形成のための分子基盤を提供します.
- RbCのリン酸化は規制スイッチとして作用し,Rb-E2F結合を調節し,それによって細胞サイクル進行を制御します.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

